Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer

被引:0
作者
Huiping Li
Guohong Song
Qiaoxia Zhou
Ran Ran
Hanfang Jiang
Ruyan Zhang
Yaxin Liu
Jiayang Zhang
Luping Meng
Liandong Ma
Ye Sun
Meiyu Wang
Qingqing Zhou
Honghua Yan
Qianxiang Zhou
Xunwei Dong
Youzhi Tong
机构
[1] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology
[2] Kintor Pharmaceutical Limited,undefined
来源
Breast Cancer Research and Treatment | 2021年 / 189卷
关键词
Androgen receptor antagonist; Proxalutamide; GT0918; Metastasis breast cancer; Preclinical data; Phase I clinical trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:725 / 736
页数:11
相关论文
共 126 条
[1]  
Eileen Tan MH(2015)Androgen receptor: structure, role in prostate cancer and drug discovery Acta Pharmacol Sin 36 3-23
[2]  
Li J(2019)Consideration of breast cancer subtype in targeting the androgen receptor Pharmacol Ther 200 135-147
[3]  
Eric Xu H(1998)Role of the androgen receptor in human breast cancer J Mammary Gland Biol Neoplasia 3 95-103
[4]  
Melcher K(2004)Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic tool Arch Surg 139 50-54
[5]  
Yong E-l(2016)Targeting the androgen receptor in triple-negative breast cancer Curr Probl Cancer 40 141-150
[6]  
Venema CM(2010)Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation Modern Pathol 23 205-212
[7]  
Bense RD(2011)Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study Modern Pathol 24 924-931
[8]  
Steenbruggen TG(2017)AR signaling in breast cancer Cancers 9 21-1874
[9]  
Nienhuis HH(2011)Androgen receptor expression and breast cancer survival in postmenopausal women Clin Cancer Res 17 1867-1273
[10]  
Qiu S-Q(2017)Androgen receptor function and androgen receptor-targeted therapies in breast cancer: a review JAMA Oncol 3 1266-150